An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors. [PDF]
Choucair K +4 more
europepmc +1 more source
Fetal cardiac rhabdomyomas susceptible to prenatal treatment with mTOR inhibitors: literature review and proposal of a prenatal management algorithm. [PDF]
Martinez-Garcia A +9 more
europepmc +1 more source
The role of mammalian target of rapamycin inhibitors in mitigating cyclophosphamide-induced ovarian damage in a murine model. [PDF]
Kim SK, Jee BC.
europepmc +1 more source
Enhanced antitumor efficacy of sorafenib and everolimus combination in pancreatic neuroendocrine neoplasms through mTOR inhibition. [PDF]
Zheng H +8 more
europepmc +1 more source
mTOR inhibition sensitizes T-ALL cells to Venetoclax through engagement of the integrated stress response. [PDF]
Urso L +6 more
europepmc +1 more source
Liver metastases of hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer patients: an ominous sign. [PDF]
Wang PH.
europepmc +1 more source
Impact of diabetes mellitus on one-year outcomes of bioresorbable versus durable polymer drug-eluting stents in patients undergoing percutaneous coronary intervention following rotational atherectomy: Results from a large prospective registry. [PDF]
Siano M +22 more
europepmc +1 more source
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review. [PDF]
Hernandez-Felix JH +5 more
europepmc +1 more source

